The U.S. Department of Justice (DOJ) cracked down on 35 individuals found to be tampering with genetic testing reimbursements in a fraudulent Medicare billing scheme totaling $2.1 billion. The defendants were linked to various telemedicine and telemarketing companies as well as cancer genetic testing labs for their participation in the...
